# A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

> **NCT07630545** · PHASE1 · RECRUITING · sponsor: **Mission Therapeutics** · enrollment: 106 (estimated)

## Conditions studied

- Parkinson's Disease (PD)
- Mild to Moderate Parkinson's Disease
- Early Stage Parkinson's Disease

## Interventions

- **DRUG:** MTX325
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07630545
- **Lead sponsor:** Mission Therapeutics
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-27
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2026-09-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630545, "A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07630545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*